Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Endocrinology

Pituitary adenoma

Pituitary adenoma

A pituitary adenoma is a benign tumour of the pituitary gland. They are common (10% of all people) but in most cases will never be found (asymptomatic) or are found as an incidental findings. They account for around 10% of adult brain tumours.

Pituitary adenomas can be classified according to:
  • size (a microadenoma is <1cm and a macroadenoma is ≥1cm)
  • hormonal status (a secretory/functioning adenoma produces an excess of a particular hormone and a non-secretory/functioning adenoma does not produce a hormone to excess)

Prolactinomas are the most common type and they produce an excess of prolactin. After prolactinomas, non-secreting adenomas are the next most common, then GH-secreting and then ACTH-secreting adenomas.

Pituitary adenomas typically cause symptoms by:
  • excess of a hormone (e.g. Cushing's disease due to excess ACTH, acromegaly due to excess GH or amenorrhea and galactorrhea due to excess prolactin)
  • depletion of a hormone(s) (due to compression of the normal functioning pituitary gland)
    • non-functioning tumours, therefore, present with generalised hypopituitarism
  • stretching of the dura within/around the pituitary fossa (causing headaches)
  • compression of the optic chiasm (causing a bitemporal hemianopia due to crossing nasal fibers)

Alternatively, pituitary adenomas, particularly microadenomas, can be an incidental finding on neuroimaging and therefore called a 'pituitary incidentaloma'.

Investigation requires:
  • a pituitary blood profile (including GH, prolactin, ACTH, FSH, LSH and TFTs)
  • formal visual field testing
  • MRI brain with contrast

Differential diagnoses include:
  • pituitary hyperplasia
  • craniopharyngioma
  • meningioma
  • brain metastases
  • lymphoma
  • hypophysitis
  • vascular malformation (e.g. aneurysm)

Treatment may include a combination of
  • medical therapy:
    • prolactinomas are generally treated first-line with dopamine agonists (e.g., cabergoline or bromocriptine).
    • somatostatin analogues (e.g., octreotide, lanreotide) and GH receptor antagonists (e.g., pegvisomant) are used for GH-secreting adenomas
    • for ACTH-secreting adenomas, medical therapy may include cortisol synthesis inhibitors (e.g., ketoconazole, metyrapone) and neuromodulators like pasireotide
  • transsphenoidal surgery
    • the primary treatment for most pituitary adenomas is transsphenoidal surgery, especially for non-functioning and ACTH- or GH-secreting adenomas
    • surgical intervention aims to remove the tumour mass, normalise hormone levels, and
    • non-functioning adenomas are generally diagnosed due to their compressive symptoms (e.g. visual problems) or hormone deficiencies - surgery is therefore the first-line treatment
  • radiotherapy
    • indicated for residual or recurrent tumours post-surgery
+PassMedicine Notes

A pituitary adenoma is a benign tumour of the pituitary gland. They are common (10% of all people) but in most cases will never be found (asymptomatic) or are found as an incidental findings. They account for around 10% of adult brain tumours.

Pituitary adenomas can be classified according to:
  • size (a microadenoma is


Saved ✓

MEDIA